SCHEMBL7779751

SCHEMBL7779751

C=CCn1nc(-c2ccc(S(C)(=O)=O)cc2)c(-c2ccc(Cl)cc2Cl)c1C(F)(F)F

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 16/20 0.68
PTGS1 P23219 3/20 0.41
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780141 0.91 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL7779562 0.88 PTGS2 (0.66) PTGS2PTGS1
SCHEMBL7780882 0.88 PTGS2 (0.82) PTGS2PTGS1
SCHEMBL7777327 0.85 PTGS2 (0.57) PTGS2PTGS1
SCHEMBL7772855 0.85 PTGS2 (0.53) PTGS2PTGS1
SCHEMBL7779888 0.85 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7780488 0.85 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL7778062 0.84 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7780117 0.84 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7778111 0.83 PTGS2 (0.47) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed